Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

SAB4700110

Sigma-Aldrich

Monoclonal Anti-CD19-APC antibody produced in mouse

clone LT19, purified immunoglobulin, buffered aqueous solution

Synonym(s):

Anti-CVID3

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
NACRES:
NA.41

Pricing and availability is not currently available.

biological source

mouse

Quality Level

conjugate

Allophycocyanin conjugate

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

LT19, monoclonal

form

buffered aqueous solution

species reactivity

human

technique(s)

flow cytometry: suitable

isotype

IgG1

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
SAB4700109SAB4700112SAB4700113
biological source

mouse

biological source

mouse

biological source

mouse

biological source

mouse

clone

LT19, monoclonal

clone

LT19, monoclonal

clone

LT19, monoclonal

clone

LT19, monoclonal

Gene Information

human ... CD19(930)

Gene Information

human ... CD19(930)

Gene Information

human ... CD19(930)

Gene Information

human ... CD19(930)

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

species reactivity

human

species reactivity

human

species reactivity

human

species reactivity

human

conjugate

Allophycocyanin conjugate

conjugate

unconjugated

conjugate

FITC conjugate

conjugate

phycoerythrin (R-PE) conjugate

General description

The antibody LT19 reacts with CD19 (B4), a 95 kDa type I transmembrane glycoprotein (immunoglobulin superfamily) expressed on B lymphocytes and follicular dendritic cells; it is lost on plasma cells.

Immunogen

Daudi human Burkitt lymphoma cell line

Application

The reagent is designed for Flow Cytometry analysis of human blood cells using 10 μL reagent / 100 μL of whole blood or 1e6 cells in a suspension. The content of a vial (1 mL) is sufficient for 100 tests.

Features and Benefits

Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.

Physical form

Solution in phosphate buffered saline containing 15 mM sodium azide and 0.2% high-grade protease free BSA as a stabilizing agent.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

wgk_germany

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A complication of self-poisoning.
C H Gerrand et al.
Postgraduate medical journal, 73(856), 113-114 (1997-02-01)
S L Levin
International journal of clinical pharmacology research, 6(5), 429-439 (1986-01-01)
Dualism in the effects of atropine, and metixene upon the denervated human parotid salivary gland is demonstrated by the fact that they suppress pilocarpine secretion while themselves causing an extremely intense and prolonged salivation. A still stronger cholinolytic, chlorosyle, although
[The treatment of Parkinson tremors and forms of extrapyramidal tremors with methixene. A multicenter study].
E Volles et al.
Die Medizinische Welt, 34(24), 707-709 (1983-06-17)
P A Fischer et al.
Journal of neural transmission. Supplementum, 25, 137-147 (1987-01-01)
To quantify the clinical benefit of an additional deprenyl administration in L-dopa pretreated patients we have performed a study of 30 patients suffering from advanced parkinsonism. During the first phase of the study over three months under controlled conditions deprenyl
[Treatment of extrapyramidal tremors in the aged].
D Hust
Die Medizinische Welt, 32(19), 743-746 (1981-05-08)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service